**Core Concept:** Tourette's Disorder is a neurodevelopmental disorder characterized by motor and vocal tics, often associated with co-morbidities like ADHD and obsessive-compulsive disorder. In children, it is often triggered by exposure to neuroleptic drugs used for the treatment of other conditions.

**Why the Correct Answer is Right:** Given the child's history of ADHD, Tourette's Disorder is a likely diagnosis. Neuroleptic drugs are known to trigger or exacerbate Tourette's symptoms. Therefore, considering the child has never been on pharmacotherapy for ADHD, the clinician would consider starting treatment with a medication that has minimal risk of triggering Tourette's symptoms.

**Why Each Wrong Option is Incorrect:**

A. **Atomoxetine (Option A)**: Although effective in treating ADHD, atomoxetine is a selective norepinephrine reuptake inhibitor that can potentially trigger or worsen Tourette's Disorder symptoms due to its effect on norepinephrine neurotransmission.

B. **Methylphenidate (Option B)**: Similar to atomoxetine, methylphenidate is a dopamine and norepinephrine reuptake inhibitor, increasing the risk of triggering or worsening Tourette's Disorder symptoms.

C. **Vitamin B12 deficiency (Option C)**: While vitamin B12 deficiency can cause neurological symptoms, it is not the primary treatment for Tourette's Disorder. The focus should be on selecting a medication with minimal risk of worsening Tourette's Disorder symptoms.

D. **Emergency Treatment for Acute Depression (Option D)**: The question does not mention depression as a co-morbidity, nor does it mention any urgent treatment for depression. The main focus is to minimize the risk of worsening Tourette's Disorder symptoms, and none of the options address this concern.

**Clinical Pearl:** Tourette's Disorder co-occurring with ADHD is a common presentation in pediatric neurology. Choosing a medication with minimal risk of worsening Tourette's Disorder symptoms is crucial. In such cases, clinicians usually opt for alpha-agonists or alpha-blockers which are less likely to trigger or exacerbate Tourette's Disorder symptoms.

**Correct Answer: Option D (Emergency Treatment for Acute Depression)**

The correct answer is not mentioned in the options provided. However, given the child's presentation and the focus on minimizing Tourette's Disorder worsening risk, clinicians would choose a medication with minimal risk of triggering or worsening Tourette's Disorder symptoms. In this case, the correct choice would be an alpha-agonist or alpha-blocker, as these drugs have fewer chances of worsening Tourette's Disorder symptoms compared to dopaminergic or serotonergic medications.